Login / Signup

Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease.

Rebecka Ventin-HolmbergAnja EberlSchahzad SaqibKatri KorpelaSeppo VirtanenTaina SipponenAnne SalonenPäivi SaavalainenEija Nissilä
Published in: Journal of Crohn's & colitis (2021)
Faecal bacterial and fungal microbiota composition could provide a predictive tool to estimate IFX response in IBD patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • ulcerative colitis
  • emergency department
  • drug induced